Configuration and <i>E</i>/<i>Z</i> interconversion mechanism of <i>O</i>(<i>S</i>)‐allyl‐<i>S</i>(<i>O</i>)‐methyl‐<i>N</i>‐(acridin‐9‐yl) iminothiocarbonate
Karel D. Klika(German Cancer Research Center), Erich Kleinpeter(University of Potsdam), Slávka Hamuľaková(University of Pavol Jozef Šafárik), Stanislav Böhm(University of Chemistry and Technology, Prague), Andreas Koch(University of Potsdam), Ivan Danihel, Kalevi Pihlaja(University of Turku), Ján Imrich, Pavol Kristián(Evotec (United States))
Cited by 9
Related Papers
Applications of fluorine-containing amino acids for drug design
|European Journal of Medicinal Chemistry|2019|238
The present and future disease burden of hepatitis <scp>C</scp> virus (<scp>HCV</scp>) infections with today's treatment paradigm – volume 2
|Journal of Viral Hepatitis|2015|125
Synthesis and Biological Evaluation of Novel Tacrine Derivatives and Tacrine–Coumarin Hybrids as Cholinesterase Inhibitors
|Journal of Medicinal Chemistry|2014|112
Effect of Increased Lactate Dehydrogenase A Activity and Aerobic Glycolysis on the Proinflammatory Profile of Autoimmune CD8+ T Cells in Rheumatoid Arthritis
|Arthritis & Rheumatology|2020|98
Historical epidemiology of hepatitis C virus (<scp>HCV</scp>) in select countries – volume 2
|Journal of Viral Hepatitis|2015|93